Italia markets closed

Safe Orthopaedics SA (0RAA.L)

LSE - LSE Prezzo differito. Valuta in EUR.
Aggiungi a watchlist
0,2770+0,0015 (+0,54%)
Alla chiusura: 07:15AM GMT
Schermo intero
Chiusura precedente0,2755
Aperto0,0000
Denaro0,0000 x 0
Lettera0,0000 x 0
Min-Max giorno0,0000 - 0,0000
Intervallo di 52 settimane
Volume0
Media VolumeN/D
Capitalizzazione95.237
Beta (5 anni mensile)1,63
Rapporto PE (ttm)N/D
EPS (ttm)-2,2180
Prossima data utiliN/D
Rendimento e dividendo (forward)N/D (N/D)
Data ex dividendoN/D
Stima target 1AN/D
  • GlobeNewswire

    Safe announces the reverse stock split of 1 new share for 3,700 existing shares

    Safe announces the reverse stock split of 1 new share for 3,700 existing shares ► Consolidation by way of exchange of 3,700 existing shares for 1 new share Start of the reverse split on Thursday, January 26, 2023 Consolidation takes effect on Monday, February 27, 2023 Suspension of the right to exercise the securities giving access to the capital from Tuesday, January 10, 2023 (inclusive) to Friday, February 24, 2023 (inclusive) Éragny-sur-Oise, France, January 12, 2023, 5:30 p.m. - Safe (FR0013

  • GlobeNewswire

    Safe group announces consolidated annual sales of €5.9M, up 26%

    43% growth in direct sales for Safe Orthopaedics 20% growth in outsourced production sales 25,000 surgeries performed with Ready to Use technology Eragny-sur-Oise, France, January 11th, 2023 8:45 CET – Safe (FR0013467123 – ALSAF), a company specializing in the design, manufacturing and marketing of ready-to-use technologies for orthopedic surgeries, especially for back surgery, announces its 2022 annual revenue and its cash position. In thousands euroNon audited figures2021(12 months)2021(12 mon

  • GlobeNewswire

    Safe announces the convocation of an extraordinary general meeting of the Company to be held on December 16, 2022

    Convocation of an extraordinary general meeting called to vote on the delegation of authority to the Company's Board of Directors to proceed with (i) the reverse stock split of the Company's shares by the allocation of one (1) new ordinary share with a par value of twelve (12) euros each against one thousand two hundred (1. 200) old ordinary shares, (ii) a reduction in the Company's share capital due to losses within the limit of 10% more or less of an amount of € 5,000,000 and (iii) an increase